Clade Ther­a­peu­tics cuts staff and ap­pears to shut down Eu­ro­pean sub­sidiary

Clade Ther­a­peu­tics, which is de­vel­op­ing off-the-shelf cell ther­a­pies, has dis­missed a num­ber of staffers in the US and Eu­rope, ac­cord­ing to so­cial me­dia posts made by em­ploy­ees and a top ex­ec­u­tive at the com­pa­ny.

“Yes­ter­day, at Clade we went through the painful process of a ‘re­duc­tion in force’ and part­ed ways with many of our valu­able col­leagues,” chief busi­ness of­fi­cer and co-founder Jim Glasheen wrote in his LinkedIn post sev­er­al days ago.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER